Skip to main content

Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Artificial Intelligence Feasible for Localizing Acute Stroke Lesions

WEDNESDAY, March 27, 2024 -- Large language models (LLMs) such as Generative Pretrained Transformers (GPTs) can potentially localize acute stroke lesions...

ACC: Short Sleep Duration Linked to Risk of Developing Hypertension

WEDNESDAY, March 27, 2024 -- Short sleep duration is associated with an increased risk of developing hypertension, according to a study scheduled for...

Supervised Exercise Improves Patient-Reported Outcomes for Metastatic Breast Cancer

WEDNESDAY, March 27, 2024 -- Supervised exercise during palliative treatment leads to beneficial effects on fatigue and health-related quality of life (HRQoL)...

Timing of Pubertal Development Tied to Adult Cardiometabolic Risk

WEDNESDAY, March 27, 2024 -- Pubertal development and its timing may be an important pathway through which early-life exposures shape adulthood...

EHR Scheduling Aids Operating Room Scheduling Accuracy

WEDNESDAY, March 27, 2024 -- The use of electronic health record (EHR) systems for predicting operation times improves operating room (OR) scheduling accuracy...

Obesity Genes Mean Some Folks Must Exercise More for Same Results

WEDNESDAY, March 27, 2024 -- Some folks struggling with obesity appear to be hampered by their own genes when it comes to working off those extra pounds, a new...

ADHD Meds Tied to Heart Damage in Young Adult Users

WEDNESDAY, March 27, 2024 -- ADHD stimulant medications like Ritalin or Adderall appear linked to a heightened risk for cardiomyopathy (a weakening of the...

Sleep Troubles Can Raise Your Blood Pressure: Study

WEDNESDAY, March 27, 2024 -- A major review of data confirms that getting less than the recommended amount of sleep each night is a risk factor for high blood...

SCOTUS Appears Skeptical of Arguments to Curb Abortion Pill Access

WEDNESDAY, March 27, 2024 -- Following oral arguments presented on Tuesday, the U.S. Supreme Court looked poised to rebuff a legal challenge to women's access...

Could Regular Exercise Cure Your Insomnia? New Research Says Yes

WEDNESDAY, March 27, 2024 -- Folks who consistently work out two to three times a week are less likely to suffer from insomnia, a new study says. That sort of...

FDA Approves Winrevair (sotatercept-csrk) a First-in-Class Treatment for Adults with Pulmonary Arterial Hypertension

RAHWAY, N.J.--(BUSINESS WIRE) March 26, 2024 -- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the U.S. Food...

FDA Approves Medexus's Supplemental Biologics License Application for Ixinity to Treat Hemophilia B in Pediatric Patients

Toronto, Ontario and Chicago, Illinois-- March 26, 2024 - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) today announced that the US Food and Drug...

Ultomiris Approved in the US for the Treatment of Adults with Neuromyelitis Optica Spectrum Disorder (NMOSD)

25 March 2024 -- Ultomiris (ravulizumab-cwvz) has been approved in the United States (US) as the first and only long-acting C5 complement inhibitor for the...

Regeneron Provides Update on Biologics License Application for Odronextamab

TARRYTOWN, N.Y., March 25, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration...

FDA Approves Duvyzat (givinostat) for Duchenne Muscular Dystrophy

MILAN--(BUSINESS WIRE)-- Mar 22, 2024 -- Italfarmaco S.p.A. announced today that the U.S. Food and Drug Administration (FDA) has approved Duvyzat&trade...

FDA Approves Opsynvi (macitentan and tadalafil) for Adults with Pulmonary Arterial Hypertension

RARITAN, NJ, March 22, 2024 – Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved Opsynvi® – a...

Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea

SCOTTSDALE, Ariz., March 18, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”)...

U.S. Food and Drug Administration (FDA) Has Accepted the New Drug Application (NDA) for Ensartinib

MIAMI--(BUSINESS WIRE) March 13, 2024 --Xcovery Holdings, Inc., an oncology focused pharmaceutical company, today announced that the U.S. Food and Drug...

Lumicell Announces FDA Advisory Committee’s Positive Recommendation on the Benefit-Risk Profile of Lumisight in the Detection of Cancerous Tissue During Breast Conserving Surgery

NEWTON, Massachusetts March 6, 2024 – Lumicell, Inc., a privately held company focused on innovative fluorescence-guided imaging technologies for cancer...

SpringWorks Therapeutics Initiates Rolling Submission of New Drug Application to the FDA for Mirdametinib for the Treatment of Children and Adults with NF1-PN

STAMFORD, Conn., March 04, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on...

Johnson & Johnson's Nipocalimab Granted U.S. FDA Fast Track Designation to Reduce the Risk of Fetal Neonatal Alloimmune Thrombocytopenia (FNAIT) in Alloimmunized Pregnant Adults

SPRING HOUSE, Pa. March 26, 2024 – Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track...

Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the Treatment of Prader-Willi Syndrome

CHATHAM, N.J., March 25, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with...

Invivyd Announces FDA Authorization for Emergency Use of Pemgarda (Formerly VYD222) for Pre-Exposure Prophylaxis (PrEP) of COVID-19

WALTHAM, Mass., March 22, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company on a mission to protect the vulnerable from...

Lisata Therapeutics Announces U.S. FDA Rare Pediatric Disease Designation Granted to LSTA1 for the Treatment of Osteosarcoma

BASKING RIDGE, N.J., March 21, 2024. Lisata Therapeutics, Inc. (“Lisata” or the “Company”), a clinical-stage pharmaceutical company...

HI-Bio Receives FDA Orphan Drug Designation for Felzartamab for the Treatment of Antibody-Mediated Rejection (AMR) in Kidney Transplant Recipients

SOUTH SAN FRANCISCO, Calif., – March 21, 2024 – Human Immunology Biosciences (HI-Bio™), a clinical-stage biotechnology company developing...

Browse by news type

Drugs.com Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.

Disclaimer

This library contains syndicated news articles. These articles have not been peer-reviewed by Drugs.com, and therefore we cannot guarantee accuracy to the highest ethical standards. Do further research as needed. Consultation with your physician is essential.